Pennington TE, Thompson JF, Varey AHR. ASO Author Reflections: Is Sentinel Node Biopsy Still of Value for Patients with High-Risk Primary Melanomas Eligible for Adjuvant Immunotherapy? Ann Surg Oncol 2024 Dec 27. doi: 10.1245/s10434-024-16821.
PMID: 39730968